Intrinsic Edge Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-181,984
Closed -$12.4M 133
2023
Q3
$12.4M Buy
181,984
+40,000
+28% +$3.39M 1.4% 20
2023
Q2
$13.3M Sell
141,984
-169,852
-54% -$13.2M 0.96% 35
2023
Q1
$21.1M Buy
311,836
+98,669
+46% +$6.34M 2.12% 3
2022
Q4
$10.6M Sell
213,167
-83,106
-28% -$3.4M 1.05% 36
2022
Q3
$9.63M Buy
296,273
+473
+0.2% +$19.5K 1.05% 35
2022
Q2
$11.7M Buy
295,800
+63,197
+27% +$3.38M 0.91% 41
2022
Q1
$16.3M Sell
232,603
-38,999
-14% -$2.85M 1.25% 22
2021
Q4
$21.1M Buy
+271,602
New +$24M 1.35% 14
2021
Q1
Sell
-33,841
Closed -$4.48M 237
2020
Q4
$4.48M Hold
33,841
0.33% 99
2020
Q3
$3.45M Sell
33,841
-1,173
-3% -$101K 0.23% 149
2020
Q2
$3.04M Sell
35,014
-58,366
-63% -$4.66M 0.28% 131
2020
Q1
$5.42M Buy
93,380
+31,407
+51% +$2.55M 0.72% 48
2019
Q4
$5.73M Hold
61,973
0.72% 56
2019
Q3
$5.6M Sell
61,973
-133,874
-68% -$15.3M 0.63% 61
2019
Q2
$23.1M Buy
195,847
+49,172
+34% +$4.95M 2.75% 2
2019
Q1
$12.7M Buy
146,675
+54,297
+59% +$4.62M 2.15% 11
2018
Q4
$5.83M Buy
+92,378
New +$6.34M 0.98% 38
2018
Q3
Sell
-144,565
Closed -$9.43M 152
2018
Q2
$8.64M Sell
144,565
-55,148
-28% -$2.97M 1.02% 35
2018
Q1
$8.05M Buy
+199,713
New +$9.74M 1.23% 28
2017
Q4
Sell
-73,900
Closed -$3.48M 125
2017
Q3
$3.48M Sell
73,900
-10,000
-12% -$403K 0.69% 50
2017
Q2
$2.97M Sell
83,900
-73,802
-47% -$2.28M 0.92% 46
2017
Q1
$3.73M Buy
157,702
+123,802
+365% +$2.45M 1.15% 30
2016
Q4
$453K Buy
+33,900
New +$547K 0.19% 106

Other funds holding EXAS

Intrinsic Edge Capital Management's EXAS Position: Q4 2023 in Review

Intrinsic Edge Capital Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 181,984 shares — an estimated $12.4M sold.

Intrinsic Edge Capital Management first reported a position in EXAS in Q4 2016 and held it in 23 quarters. The position peaked at $23.1M in Q2 2019. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Intrinsic Edge Capital Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 181,984 Exact Sciences shares in Q4 2023, an estimated $12.4M.
  • Intrinsic Edge Capital Management first reported a position in Exact Sciences in Q4 2016 and held it in 23 quarters.
  • Intrinsic Edge Capital Management's Exact Sciences position peaked at $23.1M in Q2 2019.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.